annual EBITDA:
$1.48B-$280.50M(-15.93%)Summary
- As of today (August 5, 2025), EW annual EBITDA is $1.48 billion, with the most recent change of -$280.50 million (-15.93%) on December 31, 2024.
- During the last 3 years, EW annual EBITDA has fallen by -$375.10 million (-20.22%).
- EW annual EBITDA is now -23.16% below its all-time high of $1.93 billion, reached on December 31, 2022.
Performance
EW EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$430.90M-$15.60M(-3.49%)Summary
- As of today (August 5, 2025), EW quarterly EBITDA is $430.90 million, with the most recent change of -$15.60 million (-3.49%) on June 30, 2025.
- Over the past year, EW quarterly EBITDA has increased by +$14.10 million (+3.38%).
- EW quarterly EBITDA is now -48.53% below its all-time high of $837.20 million, reached on December 31, 2014.
Performance
EW quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$1.79B+$14.10M(+0.79%)Summary
- As of today (August 5, 2025), EW TTM EBITDA is $1.79 billion, with the most recent change of +$14.10 million (+0.79%) on June 30, 2025.
- Over the past year, EW TTM EBITDA has increased by +$274.50 million (+18.11%).
- EW TTM EBITDA is now -9.43% below its all-time high of $1.98 billion, reached on September 30, 2022.
Performance
EW TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
EW EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -15.9% | +3.4% | +18.1% |
3 y3 years | -20.2% | -10.0% | -6.6% |
5 y5 years | +15.9% | +69.5% | +38.8% |
EW EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -23.2% | at low | -12.0% | +85.7% | -9.4% | +18.1% |
5 y | 5-year | -23.2% | +42.4% | -18.7% | +4342.3% | -9.4% | +72.2% |
alltime | all time | -23.2% | +1725.0% | -48.5% | +1287.0% | -9.4% | +3791.1% |
EW EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $430.90M(-3.5%) | $1.79B(+0.8%) |
Mar 2025 | - | $446.50M(-7.7%) | $1.78B(+2.9%) |
Dec 2024 | $1.48B(-15.9%) | $483.70M(+12.8%) | $1.73B(+12.1%) |
Sep 2024 | - | $428.80M(+2.9%) | $1.54B(+1.6%) |
Jun 2024 | - | $416.80M(+5.1%) | $1.52B(-0.3%) |
Mar 2024 | - | $396.40M(+33.4%) | $1.52B(-4.5%) |
Dec 2023 | $1.76B(-8.6%) | $297.20M(-26.6%) | $1.59B(+4.3%) |
Sep 2023 | - | $405.00M(-3.7%) | $1.53B(-5.3%) |
Jun 2023 | - | $420.60M(-10.1%) | $1.61B(-3.5%) |
Mar 2023 | - | $467.80M(+101.6%) | $1.67B(-0.6%) |
Dec 2022 | $1.93B(+3.8%) | $232.10M(-52.6%) | $1.68B(-15.1%) |
Sep 2022 | - | $489.70M(+2.3%) | $1.98B(+3.1%) |
Jun 2022 | - | $478.80M(+0.2%) | $1.92B(+0.1%) |
Mar 2022 | - | $477.70M(-9.9%) | $1.92B(+3.2%) |
Dec 2021 | $1.86B(+78.4%) | $530.00M(+23.3%) | $1.86B(+39.0%) |
Sep 2021 | - | $429.70M(-10.0%) | $1.33B(+3.6%) |
Jun 2021 | - | $477.70M(+14.3%) | $1.29B(+21.0%) |
Mar 2021 | - | $417.80M(+4207.2%) | $1.06B(+2.4%) |
Dec 2020 | $1.04B(-18.6%) | $9.70M(-97.5%) | $1.04B(-22.9%) |
Sep 2020 | - | $382.80M(+50.5%) | $1.35B(+4.6%) |
Jun 2020 | - | $254.30M(-35.3%) | $1.29B(-3.7%) |
Mar 2020 | - | $392.90M(+23.1%) | $1.34B(+4.9%) |
Dec 2019 | $1.28B(+46.9%) | $319.20M(-1.2%) | $1.28B(+29.3%) |
Sep 2019 | - | $323.00M(+6.2%) | $987.60M(+5.7%) |
Jun 2019 | - | $304.20M(-7.8%) | $934.20M(+1.8%) |
Mar 2019 | - | $330.10M(+989.4%) | $917.70M(+5.6%) |
Dec 2018 | $868.70M(-23.8%) | $30.30M(-88.8%) | $868.70M(-23.5%) |
Sep 2018 | - | $269.60M(-6.3%) | $1.14B(+2.5%) |
Jun 2018 | - | $287.70M(+2.3%) | $1.11B(+1.6%) |
Mar 2018 | - | $281.10M(-5.4%) | $1.09B(-4.4%) |
Dec 2017 | $1.14B(+37.6%) | $297.20M(+23.1%) | $1.14B(+9.6%) |
Sep 2017 | - | $241.40M(-10.8%) | $1.04B(+2.7%) |
Jun 2017 | - | $270.70M(-18.1%) | $1.01B(+7.6%) |
Mar 2017 | - | $330.70M(+67.6%) | $940.60M(+13.6%) |
Dec 2016 | $828.30M(+17.4%) | $197.30M(-7.6%) | $828.30M(+1.4%) |
Sep 2016 | - | $213.60M(+7.3%) | $817.10M(+5.1%) |
Jun 2016 | - | $199.00M(-8.9%) | $777.80M(+4.8%) |
Mar 2016 | - | $218.40M(+17.4%) | $742.40M(+5.2%) |
Dec 2015 | $705.40M(-42.6%) | $186.10M(+6.8%) | $705.40M(-48.0%) |
Sep 2015 | - | $174.30M(+6.5%) | $1.36B(+2.0%) |
Jun 2015 | - | $163.60M(-9.8%) | $1.33B(+2.2%) |
Mar 2015 | - | $181.40M(-78.3%) | $1.30B(+5.8%) |
Dec 2014 | $1.23B(+110.6%) | $837.20M(+467.6%) | $1.23B(+110.2%) |
Sep 2014 | - | $147.50M(+8.9%) | $585.20M(+4.5%) |
Jun 2014 | - | $135.40M(+23.4%) | $560.20M(-1.0%) |
Mar 2014 | - | $109.70M(-43.0%) | $566.00M(-3.1%) |
Dec 2013 | $583.90M(+30.8%) | $192.60M(+57.2%) | $583.90M(+11.6%) |
Sep 2013 | - | $122.50M(-13.2%) | $523.30M(+2.7%) |
Jun 2013 | - | $141.20M(+10.7%) | $509.50M(+7.6%) |
Mar 2013 | - | $127.60M(-3.3%) | $473.40M(+6.2%) |
Dec 2012 | $446.30M | $132.00M(+21.4%) | $445.70M(+12.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2012 | - | $108.70M(+3.4%) | $398.00M(+10.0%) |
Jun 2012 | - | $105.10M(+5.2%) | $361.80M(+4.9%) |
Mar 2012 | - | $99.90M(+18.5%) | $345.00M(+0.1%) |
Dec 2011 | $344.70M(+5.4%) | $84.30M(+16.3%) | $344.70M(-0.5%) |
Sep 2011 | - | $72.50M(-17.9%) | $346.40M(-2.2%) |
Jun 2011 | - | $88.30M(-11.3%) | $354.20M(+2.2%) |
Mar 2011 | - | $99.60M(+15.8%) | $346.70M(+6.1%) |
Dec 2010 | $327.10M(-10.6%) | $86.00M(+7.1%) | $326.90M(+2.8%) |
Sep 2010 | - | $80.30M(-0.6%) | $318.00M(-8.7%) |
Jun 2010 | - | $80.80M(+1.3%) | $348.20M(+0.8%) |
Mar 2010 | - | $79.80M(+3.5%) | $345.60M(-5.5%) |
Dec 2009 | $365.80M(+61.0%) | $77.10M(-30.2%) | $365.80M(+10.4%) |
Sep 2009 | - | $110.50M(+41.3%) | $331.20M(+18.8%) |
Jun 2009 | - | $78.20M(-21.8%) | $278.80M(+3.8%) |
Mar 2009 | - | $100.00M(+135.3%) | $268.60M(+22.7%) |
Dec 2008 | $227.20M(-0.1%) | $42.50M(-26.9%) | $218.90M(-7.0%) |
Sep 2008 | - | $58.10M(-14.6%) | $235.50M(+3.3%) |
Jun 2008 | - | $68.00M(+35.2%) | $228.00M(+3.3%) |
Mar 2008 | - | $50.30M(-14.9%) | $220.80M(-3.4%) |
Dec 2007 | $227.40M(-1.1%) | $59.10M(+16.8%) | $228.50M(+0.6%) |
Sep 2007 | - | $50.60M(-16.8%) | $227.10M(-1.5%) |
Jun 2007 | - | $60.80M(+4.8%) | $230.50M(+0.4%) |
Mar 2007 | - | $58.00M(+0.5%) | $229.60M(-8.8%) |
Dec 2006 | $230.00M(-0.6%) | $57.70M(+6.9%) | $251.80M(-1.4%) |
Sep 2006 | - | $54.00M(-9.8%) | $255.40M(-0.0%) |
Jun 2006 | - | $59.90M(-25.3%) | $255.50M(-0.1%) |
Mar 2006 | - | $80.20M(+30.8%) | $255.80M(+10.4%) |
Dec 2005 | $231.50M(+10.2%) | $61.30M(+13.3%) | $231.80M(+3.1%) |
Sep 2005 | - | $54.10M(-10.1%) | $224.90M(+1.6%) |
Jun 2005 | - | $60.20M(+7.1%) | $221.40M(+3.1%) |
Mar 2005 | - | $56.20M(+3.3%) | $214.80M(+10.3%) |
Dec 2004 | $210.10M(+14.2%) | $54.40M(+7.5%) | $194.70M(+1.9%) |
Sep 2004 | - | $50.60M(-5.6%) | $191.00M(+3.7%) |
Jun 2004 | - | $53.60M(+48.5%) | $184.20M(+6.5%) |
Mar 2004 | - | $36.10M(-28.8%) | $173.00M(-4.3%) |
Dec 2003 | $184.00M(+98.9%) | $50.70M(+15.8%) | $180.70M(+5.1%) |
Sep 2003 | - | $43.80M(+3.3%) | $172.00M(+76.6%) |
Jun 2003 | - | $42.40M(-3.2%) | $97.40M(+1.8%) |
Mar 2003 | - | $43.80M(+4.3%) | $95.70M(+3.5%) |
Dec 2002 | $92.50M(+14.1%) | $42.00M(-236.4%) | $92.50M(+2.5%) |
Sep 2002 | - | -$30.80M(-175.7%) | $90.20M(-42.0%) |
Jun 2002 | - | $40.70M(+0.2%) | $155.40M(+98.2%) |
Mar 2002 | - | $40.60M(+2.3%) | $78.40M(-3.3%) |
Dec 2001 | $81.10M(-52.0%) | $39.70M(+15.4%) | $81.10M(-20.5%) |
Sep 2001 | - | $34.40M(-194.8%) | $102.00M(-4.9%) |
Jun 2001 | - | -$36.30M(-183.8%) | $107.30M(-38.5%) |
Mar 2001 | - | $43.30M(-28.5%) | $174.60M(-1.5%) |
Dec 2000 | $169.00M(-15.9%) | $60.60M(+52.6%) | $177.30M(+51.9%) |
Sep 2000 | - | $39.70M(+28.1%) | $116.70M(+51.6%) |
Jun 2000 | - | $31.00M(-32.6%) | $77.00M(+67.4%) |
Mar 2000 | - | $46.00M | $46.00M |
Dec 1999 | $201.00M | - | - |
FAQ
- What is Edwards Lifesciences Corporation annual EBITDA?
- What is the all time high annual EBITDA for Edwards Lifesciences Corporation?
- What is Edwards Lifesciences Corporation annual EBITDA year-on-year change?
- What is Edwards Lifesciences Corporation quarterly EBITDA?
- What is the all time high quarterly EBITDA for Edwards Lifesciences Corporation?
- What is Edwards Lifesciences Corporation quarterly EBITDA year-on-year change?
- What is Edwards Lifesciences Corporation TTM EBITDA?
- What is the all time high TTM EBITDA for Edwards Lifesciences Corporation?
- What is Edwards Lifesciences Corporation TTM EBITDA year-on-year change?
What is Edwards Lifesciences Corporation annual EBITDA?
The current annual EBITDA of EW is $1.48B
What is the all time high annual EBITDA for Edwards Lifesciences Corporation?
Edwards Lifesciences Corporation all-time high annual EBITDA is $1.93B
What is Edwards Lifesciences Corporation annual EBITDA year-on-year change?
Over the past year, EW annual EBITDA has changed by -$280.50M (-15.93%)
What is Edwards Lifesciences Corporation quarterly EBITDA?
The current quarterly EBITDA of EW is $430.90M
What is the all time high quarterly EBITDA for Edwards Lifesciences Corporation?
Edwards Lifesciences Corporation all-time high quarterly EBITDA is $837.20M
What is Edwards Lifesciences Corporation quarterly EBITDA year-on-year change?
Over the past year, EW quarterly EBITDA has changed by +$14.10M (+3.38%)
What is Edwards Lifesciences Corporation TTM EBITDA?
The current TTM EBITDA of EW is $1.79B
What is the all time high TTM EBITDA for Edwards Lifesciences Corporation?
Edwards Lifesciences Corporation all-time high TTM EBITDA is $1.98B
What is Edwards Lifesciences Corporation TTM EBITDA year-on-year change?
Over the past year, EW TTM EBITDA has changed by +$274.50M (+18.11%)